Technical Service Need help? Our team of experienced experts is here for you with full support.
AKA-200
Repotrectinib
Cat. No.
AKA-200
CAS No.
1802220-02-5
MF
C18H18FN5O2
MW
355.37
Repotrectinib is a potent ROS1 inhibitor.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Service 
86-28-85159085 
info@aktin.com Technical Data
Description
Storage and Shipping
References
Product Name
Repotrectinib
CAS No.
1802220-02-5
MF
C18H18FN5O2
MW
355.37
Specification
98%
Research Area
Oncology
Description
Repotrectinib is a potent ROS1 inhibitor. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g, 1kg Availability: API for research only, commercial supply only after the patent expires
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Dayong Zhai, et al. Abstract 2132: The novel, rationally-designed, ALK/SRC inhibitor TPX-0005 overcomes multiple acquired resistance mechanisms to current ALK inhibitors. Cancer Research. July 2016.
[2]. Karachaliou N, et al. Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis. EBioMedicine. 2018 Mar;29:112-127.
Related Products
AKA-377
AkProva™ Metildigoxin
CAS No.:30685-43-9(acetone-free)
MF:C42H66O14.1/2C3H6O
AKA-376
AkProva™ beta-Acetyldigoxin
CAS No.:5355-48-6
MF:C43H66O15
AKA-375
Ak-NucleoVia™ Agrostemmoside E
CAS No.:2656438-29-6
MF:C84H128O45
AKA-374
Novobiocin sodium
CAS No.:1476-53-5
MF:C31H36N2O11.Na
AKA-345
Tetrahydropalmatine
CAS No.:483-14-7
MF:C21H25NO4
AKA-360
Travoprost
CAS No.:157283-68-6
MF:C26H35F3O6
AKA-359
Berberine sulfate
CAS No.:316-41-6
MF:C20H18NO4.1/2O4S
AKA-355
Topotecan hydrochloride
CAS No.:119413-54-6
MF:C23H24ClN3O5
AKA-353
Nalmefene Hydrochloride
CAS No.:1228646-72-7
MF:C21H25NO3.ClH.H2O
AKA-347
Vigabatrin
CAS No.:68506-86-5
MF:C6H11NO2
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
